Table 3 Primary and secondary outcomes for study participants stratified by BMI
From: The effects of body mass index on outcomes for patients undergoing surgical aortic valve replacement
BMI < 20 (N = 108) | BMI 20–24.9 (N = 972) | BMI 25–29.9 (N = 1721) | BMI 30–34.9 (N = 1199) | BMI ≥ 35 (N = 780) | P value | |
|---|---|---|---|---|---|---|
Primary Outcome | ||||||
Death at 30 days | 2(1.9) | 15(1.5) | 23(1.3) | 10(0.8) | 15(1.9) | 0.313 |
Death at 1 year | 9(8.3) | 46(4.7) | 81(4.7) | 47(3.9) | 38(4.9) | 0.300 |
Death at 5 year | 19(17.6) | 126(13.0) | 229(13.3) | 150(12.5) | 100(12.8) | 0.725 |
Death at longest follow-up | 29(26.9) | 229(23.6) | 377(21.9) | 237(19.8) | 159(20.4) | 0.519 |
Secondary outcome | ||||||
Hospitalization for Myocardial Infarction | 2(1.9) | 41(4.2) | 69(4.0) | 69(5.8) | 28(3.6) | 0.061 |
Hospitalization for Stroke | 7(6.5) | 64(6.6) | 136(7.9) | 84(7.0) | 41(5.3) | 0.440 |
Redo AVR | 2(1.9) | 18(1.9) | 28(1.6) | 22(1.8) | 20(2.6) | 0.151 |